{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Anoro+Ellipta", "query": { "intervention": "Anoro Ellipta" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Anoro+Ellipta&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T05:53:45.947Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07133880", "title": "Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COPD (Chronic Obstructive Pulmonary Disease)" ], "interventions": [ { "name": "umeclidinium 62.5 µg and vilanterol 25 µg", "type": "DRUG" }, { "name": "Revefenacin 175 µg, Formoterol 20 µg", "type": "DRUG" }, { "name": "Placebo ( Revefenacin and Formoterol )", "type": "DRUG" }, { "name": "Placebo DPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 72, "start_date": "2023-12-05", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07133880" }, { "nct_id": "NCT02799784", "title": "An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "TIO/OLO", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 236, "start_date": "2016-07-14", "completion_date": "2017-04-27", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 9, "location_summary": "Clearwater, Florida • Orlando, Florida • St Louis, Missouri + 6 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Medford", "state": "Oregon" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799784" }, { "nct_id": "NCT03002389", "title": "Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Anoro Ellipta", "type": "DRUG" }, { "name": "Arnuity Ellipta", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 95, "start_date": "2017-11-05", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2024-11-18", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 1, "location_summary": "Keswick, Virginia", "locations": [ { "city": "Keswick", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03002389" }, { "nct_id": "NCT03949842", "title": "Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists", "type": "DRUG" }, { "name": "Fluticasone furoate/umeclidinium/vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 0, "start_date": "2019-06-27", "completion_date": "2022-11-30", "has_results": false, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 3, "location_summary": "Waterbury, Connecticut • Charlotte, North Carolina • Layton, Utah", "locations": [ { "city": "Waterbury", "state": "Connecticut" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Layton", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949842" }, { "nct_id": "NCT03478683", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 729, "start_date": "2018-06-25", "completion_date": "2019-03-14", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 40, "location_summary": "Gold River, California • Clearwater, Florida • DeBary, Florida + 31 more", "locations": [ { "city": "Gold River", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Edgewater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478683" }, { "nct_id": "NCT03034915", "title": "A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI 62.5/25 mcg via ELLIPTA", "type": "DRUG" }, { "name": "UMEC 62.5 mcg via ELLIPTA", "type": "DRUG" }, { "name": "Salmeterol 50 mcg via DISKUS", "type": "DRUG" }, { "name": "Placebo via ELLIPTA", "type": "DRUG" }, { "name": "Placebo via DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2696, "start_date": "2017-06-16", "completion_date": "2018-06-18", "has_results": true, "last_update_posted_date": "2020-03-11", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 37, "location_summary": "Phoenix, Arizona • Lincoln, California • Clearwater, Florida + 34 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lincoln", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03034915" }, { "nct_id": "NCT03979807", "title": "A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol/Tiotropium Bromide", "type": "DRUG" }, { "name": "Umeclidinium/ Vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "40 Years", "sex": "ALL", "summary": "1 Year to 40 Years" }, "enrollment_count": 11296, "start_date": "2019-06-10", "completion_date": "2019-06-11", "has_results": true, "last_update_posted_date": "2021-11-15", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03979807" }, { "nct_id": "NCT05169424", "title": "A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Trelegy Ellipta", "type": "DEVICE" }, { "name": "Stiolto Respimat", "type": "DEVICE" }, { "name": "Tiotropium + Olodaterol (5/5 mcg)", "type": "DRUG" }, { "name": "Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 9117, "start_date": "2021-12-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-10-19", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 1, "location_summary": "White Plains, New York", "locations": [ { "city": "White Plains", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05169424" }, { "nct_id": "NCT03478696", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 732, "start_date": "2018-06-25", "completion_date": "2019-03-18", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 42, "location_summary": "Mobile, Alabama • Bakersfield, California • Sacramento, California + 35 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478696" }, { "nct_id": "NCT02487498", "title": "Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Placebo (umeclidinium/vilanterol )", "type": "DRUG" }, { "name": "Placebo (QVA149)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 355, "start_date": "2015-07-27", "completion_date": "2016-09-06", "has_results": true, "last_update_posted_date": "2018-04-02", "last_synced_at": "2026-09-03T05:53:45.947Z", "location_count": 53, "location_summary": "Anaheim, California • Escondido, California • Riverside, California + 45 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487498" } ] }